33.13 0.00 (0.01%)
After hours: 4:44PM EDT
|Bid||31.00 x 100|
|Ask||34.00 x 200|
|Day's Range||31.50 - 33.88|
|52 Week Range||24.45 - 55.95|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 24, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.64|
The Medicines Company today announced that it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018, in New York City, NY. The Company is scheduled to present at 08:00 a.m., Eastern Time.
Esperion popped Monday after a study from Regeneron and Sanofi validated the long-term benefits of lowering LDL cholesterol.
Alnylam Pharmaceuticals (ALNY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Medicines Company today announced that randomization of more than 1,500 patients in the ORION-10 trial in the United States has been completed in only 12 weeks – considerably beating its goal of 22 weeks.
The Medicines Company today announced that it will participate in the Cowen 38th Annual Health Care Conference on Tuesday, March 13, 2018, in Boston, MA. The Company is scheduled to present at 10:00 a.m., Eastern Time.
Medicines Company shares surged 6.2% in heavy morning trade on Thursday after the company reported plans to restructure its board and reduce the number of board members from 12 to seven in a financial ...
The Medicines Company today announced that its Board of Directors has appointed Dr. Sarah Schlesinger as a new, independent Director of the Company, effective immediately.
Medicines Company (MDCO) incurs wider-than-expected loss in the fourth quarter of 2017. Moreover, the top line declines year over year on low Angiomax sales.
The Medicines Company today reported its financial results for the fourth quarter and full year ended December 31, 2017.
NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Medicines Company (NASDAQ: MDCO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018 at 8:30 AM Eastern ...
The Medicines Company today announced that the target of 400 patients randomized in the ORION-9 trial has been exceeded in 10 weeks – considerably ahead of its anticipated recruitment goal of 24 weeks.
NEW YORK, Feb. 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Workday, ...
The Medicines Company will host a conference call and webcast on Wednesday, February 21, 2018, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2017 financial results and operational developments.
The Medicines Company today announced that it will participate in the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018, in New York City.
The end of the third sentence of the first paragraph of the release should read: then followed to the end of the study at 540 days ).
Investors in Medicines Company (MDCO) need to pay close attention to the stock based on moves in the options market lately.
Stock Monitor: Melinta Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free research report on The Medicines Co. (NASDAQ: MDCO ...